Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mark Topazian"'
Autor:
Arezou Khosroshahi, Mollie N. Carruthers, Thomas C. Smyrk, John H. Stone, Suresh T. Chari, Zachary S. Wallace, Thomas E. Witzig, Philip A. Hart, Vikram Deshpande, Mark Topazian
Publikováno v:
Annals of the Rheumatic Diseases. 74:1171-1177
ObjectivesTo evaluate the efficacy of rituximab (RTX) in IgG4-related disease (IgG4-RD) in an open-label pilot trial.MethodsWe treated 30 IgG4-RD patients with two doses of RTX (1000 mg each). The participants were either treated with RTX alone (n =
Autor:
Vikram Deshpande, Suresh T. Chari, Phillip A. Hart, John H. Stone, Thomas C. Smyrk, Arezou Khosroshahi, Thomas E. Witzig, Mark Topazian, Mollie N. Carruthers, Zachary S. Wallace
Publikováno v:
Annals of the rheumatic diseases. 74(8)
We thank Yamamoto and colleagues1 for their response to our paper2 and their description of their experience with rituximab (RTX) in IgG4-related disease (IgG4-RD) in three patients. Their letter raises a number of important points pertaining to the